Consistent with this, we found that ectopic expression of SASH1 reduced breast cancer cell line viability, and so we hypothesised it could be involved in processes required for maintaining cancer cell viability in vivo, and that increasing its expression could be a novel treatment strategy. This evidence concerns the gene SASH1 and breast carcinoma.